Antiviral efficacy of favipiravir against zika and sars-cov-2 viruses in non-human primates

HIGHLIGHTS

• who: Romain Marlin from the (UNIVERSITY) have published the research work: Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates, in the Journal: (JOURNAL) of 17/03/2022
• what: The authors evaluate the antiviral activity of favipiravir against Zika or SARS-CoV-2 virus in cynomolgus macaques.
• how: To support ongoing and future clinical evaluations of favipiravir against SARS-CoV-2 and Zika infections and more generally against future emerging RNA viruses the authors designed three successive experiments in cynomolgus macaques (Fig 1). In a second experiment . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.